Home
/
Nu-Med Plus, Inc.
/
Financials
/
Quarterly
Nu-Med Plus, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Nu-Med Plus, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2021
Mar 31, 2021
$0
May 17, 2021
Q3
2020
Sep 30, 2020
$0
Nov 16, 2020
Q2
2020
Jun 30, 2020
$0
Aug 19, 2020
Q1
2021
Mar 31, 2020
$0
May 17, 2021
Q3
2020
Sep 30, 2019
$0
Nov 16, 2020
Q2
2020
Jun 30, 2019
$0
Aug 19, 2020
Q1
2020
Mar 31, 2019
$0
May 14, 2020
Q3
2019
Sep 30, 2018
$0
Nov 14, 2019
Q2
2019
Jun 30, 2018
$0
Aug 14, 2019
Q1
2019
Mar 31, 2018
$0
May 15, 2019
Q3
2018
Sep 30, 2017
$0
Nov 19, 2018
Q2
2018
Jun 30, 2017
$0
Aug 2, 2018
Q1
2018
Mar 31, 2017
$0
May 11, 2018
Q3
2017
Sep 30, 2016
$0
Nov 14, 2017
Q2
2017
Jun 30, 2016
$0
Aug 18, 2017
Q1
2017
Mar 31, 2016
$0
May 17, 2017
Q3
2016
Sep 30, 2015
$0
Nov 9, 2016
Q2
2016
Jun 30, 2015
$0
Aug 15, 2016
Q1
2016
Mar 31, 2015
$0
May 16, 2016
Q3
2015
Sep 30, 2014
$0
Nov 23, 2015
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
($18.7K)
Nov 14, 2024
Q3
2024
Jun 30, 2024
($17.3K)
Nov 14, 2024
Q1
2024
Mar 31, 2024
($21.8K)
May 15, 2024
Q3
2024
Mar 31, 2024
($21.8K)
Nov 14, 2024
Q3
2024
Sep 30, 2023
($16.4K)
Nov 14, 2024
Q3
2024
Jun 30, 2023
($24.3K)
Nov 14, 2024
Q2
2023
Jun 30, 2023
($24.3K)
Aug 11, 2023
Q2
2023
Mar 31, 2023
($28.2K)
Aug 11, 2023
Q3
2024
Mar 31, 2023
($28.2K)
Nov 14, 2024
Q1
2024
Mar 31, 2023
($28.2K)
May 15, 2024
Q3
2023
Sep 30, 2022
($58.1K)
Nov 1, 2023
Q2
2023
Jun 30, 2022
($58.1K)
Aug 11, 2023
Q3
2023
Jun 30, 2022
($58.1K)
Nov 1, 2023
Q1
2023
Mar 31, 2022
($56.7K)
May 10, 2023
Q3
2023
Mar 31, 2022
($56.7K)
Nov 1, 2023
Q2
2023
Mar 31, 2022
($56.7K)
Aug 11, 2023
Q3
2021
Sep 30, 2021
($118.4K)
Nov 15, 2021
Q2
2021
Jun 30, 2021
($242.6K)
Aug 16, 2021
Q3
2021
Jun 30, 2021
($242.6K)
Nov 15, 2021
Q1
2022
Mar 31, 2021
($356.7K)
May 16, 2022
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
($17.4K)
Nov 14, 2024
Q1
2024
Mar 31, 2024
($20.6K)
May 15, 2024
Q3
2024
Sep 30, 2023
($15.1K)
Nov 14, 2024
Q2
2023
Jun 30, 2023
($23.1K)
Aug 11, 2023
Q1
2024
Mar 31, 2023
($27.0K)
May 15, 2024
Q3
2023
Sep 30, 2022
($58.1K)
Nov 1, 2023
Q2
2023
Jun 30, 2022
($58.1K)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($59.7K)
May 10, 2023
Q3
2021
Sep 30, 2021
($118.4K)
Nov 15, 2021
Q2
2021
Jun 30, 2021
($252.0K)
Aug 16, 2021
Q1
2022
Mar 31, 2021
($356.7K)
May 16, 2022
Q3
2021
Sep 30, 2020
($449.8K)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($904.4K)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($149.3K)
May 17, 2021
Q3
2020
Sep 30, 2019
($146.2K)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($243.8K)
Aug 19, 2020
Q1
2020
Mar 31, 2019
($423.7K)
May 14, 2020
Q3
2019
Sep 30, 2018
($522.1K)
Nov 14, 2019
Q2
2019
Jun 30, 2018
($168.7K)
Aug 14, 2019
Q1
2019
Mar 31, 2018
($142.6K)
May 15, 2019